ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04146	Peroxisome	9/78	89/7206	4.03021662596e-07
ko04621	NOD-like receptor signaling pathway	7/78	157/7206	0.00147344538376
ko05340	Primary immunodeficiency	3/78	30/7206	0.00401422046703
ko00561	Glycerolipid metabolism	4/78	63/7206	0.00466728322724
ko00982	Drug metabolism - cytochrome P450	3/78	37/7206	0.00727732865851
ko00980	Metabolism of xenobiotics by cytochrome P450	3/78	40/7206	0.00904168285092
ko04612	Antigen processing and presentation	4/78	77/7206	0.00946475806795
ko05145	Toxoplasmosis	5/78	126/7206	0.0115277600008
ko05204	Chemical carcinogenesis	3/78	48/7206	0.0148827772403
ko00380	Tryptophan metabolism	3/78	50/7206	0.0166081684229
ko00120	Primary bile acid biosynthesis	2/78	20/7206	0.0193735114222
ko04658	Th1 and Th2 cell differentiation	4/78	96/7206	0.0199290862152
ko04064	NF-kappa B signaling pathway	4/78	96/7206	0.0199290862152
ko00940	Phenylpropanoid biosynthesis	1/78	2/7206	0.0215329464633
ko00053	Ascorbate and aldarate metabolism	2/78	22/7206	0.0232288034057
ko04142	Lysosome	5/78	151/7206	0.0234698965846
ko04659	Th17 cell differentiation	4/78	106/7206	0.0275003157808
ko00511	Other glycan degradation	2/78	26/7206	0.0317869230228
ko04217	Necroptosis	5/78	178/7206	0.0431937743154
ko05014	Amyotrophic lateral sclerosis (ALS)	3/78	74/7206	0.0457340537372
ko01524	Platinum drug resistance	3/78	76/7206	0.048850897354